EP0180878A3 - Heterodimerischer Rezeptor von T-Lymphozyten - Google Patents

Heterodimerischer Rezeptor von T-Lymphozyten Download PDF

Info

Publication number
EP0180878A3
EP0180878A3 EP85113658A EP85113658A EP0180878A3 EP 0180878 A3 EP0180878 A3 EP 0180878A3 EP 85113658 A EP85113658 A EP 85113658A EP 85113658 A EP85113658 A EP 85113658A EP 0180878 A3 EP0180878 A3 EP 0180878A3
Authority
EP
European Patent Office
Prior art keywords
lymphocyte receptor
heterodimeric
subunits
constant
cdna clones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP85113658A
Other languages
English (en)
French (fr)
Other versions
EP0180878A2 (de
Inventor
Haruo Saito
David M. Kranz
Herman N. Eisen
Susumu Tonegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of EP0180878A2 publication Critical patent/EP0180878A2/de
Publication of EP0180878A3 publication Critical patent/EP0180878A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP85113658A 1984-10-31 1985-10-26 Heterodimerischer Rezeptor von T-Lymphozyten Withdrawn EP0180878A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/666,988 US4873190A (en) 1984-06-13 1984-10-31 Heterodimeric T lymphocyte receptor
US666988 1984-10-31

Publications (2)

Publication Number Publication Date
EP0180878A2 EP0180878A2 (de) 1986-05-14
EP0180878A3 true EP0180878A3 (de) 1987-05-06

Family

ID=24676356

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85113658A Withdrawn EP0180878A3 (de) 1984-10-31 1985-10-26 Heterodimerischer Rezeptor von T-Lymphozyten

Country Status (3)

Country Link
US (1) US4873190A (de)
EP (1) EP0180878A3 (de)
JP (1) JPS61257998A (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
EP0570027B1 (de) 1984-03-01 1999-12-29 The Board Of Trustees Of The Leland Stanford Junior University T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
KR960001741B1 (ko) * 1985-12-03 1996-02-05 티 셀 사이언시즈, 인코포레이티드 세포-없는 t 세포항원 수용체 단백질의 감지방법
ATE144791T1 (de) * 1987-06-23 1996-11-15 Univ Leland Stanford Junior Innerhalb des alpha-locus gelegenes t-zell- rezeptor-gen und dna-konstruktionen
US5906936A (en) * 1988-05-04 1999-05-25 Yeda Research And Development Co. Ltd. Endowing lymphocytes with antibody specificity
IL86278A (en) * 1988-05-04 2003-06-24 Yeda Res & Dev Endowing cells with antibody specificity using chimeric t cell receptor
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5851828A (en) 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5843728A (en) * 1991-03-07 1998-12-01 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US5445940A (en) * 1991-08-28 1995-08-29 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
US5747036A (en) * 1991-08-28 1998-05-05 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
IL104570A0 (en) 1992-03-18 1993-05-13 Yeda Res & Dev Chimeric genes and cells transformed therewith
US8211422B2 (en) 1992-03-18 2012-07-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric receptor genes and cells transformed therewith
WO1993022455A1 (en) * 1992-04-30 1993-11-11 Taisho Pharmaceutical Co., Ltd. Method of detecting expression of t-cell antigen receptor gene
US5552300A (en) * 1994-01-13 1996-09-03 T Cell Sciences, Inc. T cell antigen receptor V region proteins and methods of preparation thereof
GB9423085D0 (en) * 1994-11-16 1995-01-04 Stringer Bradley M J Targeted T lymphocytes
US6087096A (en) * 1995-11-13 2000-07-11 Dau; Peter C. Method of intrafamily fragment analysis of the T cell receptor α and β chain CDR3 regions
EP1029918A4 (de) * 1997-09-26 2003-01-02 Kyowa Hakko Kogyo Kk Rezeptor von tötenden t-zellen, die den menschlichen immunodefizienz virus erkennen
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
WO2002046400A2 (en) * 2000-12-08 2002-06-13 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
US20080064631A1 (en) * 2006-01-13 2008-03-13 Jeffrey Molldrem T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
WO2016014725A1 (en) 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
US10556545B2 (en) 2015-06-29 2020-02-11 Royal Truck & Equipment, Inc. Over-cab rack for traffic delineators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149548A2 (de) * 1984-01-13 1985-07-24 Ontario Cancer Institute Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure
WO1985003947A1 (en) * 1984-03-01 1985-09-12 The Board Of Trustees Of The Leland Stanford Jr. U T-cell receptor-specific for antigen polypeptides and related polynucleotides
EP0200350A2 (de) * 1985-04-15 1986-11-05 The Ontario Cancer Institute Nukleinsäure mit Code für ein T-Zellen-Antigenrezeptor-Polypeptid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149548A2 (de) * 1984-01-13 1985-07-24 Ontario Cancer Institute Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure
WO1985003947A1 (en) * 1984-03-01 1985-09-12 The Board Of Trustees Of The Leland Stanford Jr. U T-cell receptor-specific for antigen polypeptides and related polynucleotides
EP0200350A2 (de) * 1985-04-15 1986-11-05 The Ontario Cancer Institute Nukleinsäure mit Code für ein T-Zellen-Antigenrezeptor-Polypeptid

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CELL, vol. 34, October 1983, pages 717-726, MT; O. ACUTO et al.: "The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors" *
CELL, vol. 34, October 1983, pages 727-737, MT; J. KAPPLER et al.: "The mouse T cell receptor: comparison of MHC-restricted receptors on two T cell hybridomas" *
NATURE, vol. 308, 8th March 1984, pages 145-149; Y. YANAGI et al.: "A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains" *
NATURE, vol. 308, 8th March 1984, pages 153-158; S.M. HEDRICK et al.: "Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins" *
NATURE, vol. 309, 28th June 1984, pages 757-762; H. SAITO et al.: "Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences" *
NATURE, vol. 312, 1st November 1984, pages 36-40; H. SAITO et al.: "A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes" *

Also Published As

Publication number Publication date
EP0180878A2 (de) 1986-05-14
JPS61257998A (ja) 1986-11-15
US4873190A (en) 1989-10-10

Similar Documents

Publication Publication Date Title
EP0180878A3 (de) Heterodimerischer Rezeptor von T-Lymphozyten
CA2021594C (en) Antibody to human interleukin-6 receptor
Robb et al. Purification and partial sequence analysis of human T-cell growth factor.
Moingeon et al. A γ-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity
DE69435157D1 (de) Monoklonale antikörper die ligandbindung an den cd22-rezeptor in reifen b-zellen unterbinden.
WO1988009818A2 (en) Growth hormone receptor
WO1999029732A3 (en) Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
NL300005I2 (nl) Chimerische immuunglobulinen met specificiteit voor p55-TAC-eiwit van de IL-2-receptor.
GR3034352T3 (en) Novel polypeptides for promoting cell attachment.
Lock et al. Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor.
Gascan et al. Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor: Differentiation inhibitory activity secreted by AT lymphoma cell line
KR19980066046A (ko) 고역가의 CTLA4-Ig 융합단백질
ATE295887T1 (de) Heterodimerebildende hybrid-proteine
KR870004137A (ko) 항인간 인터로이킨 1항체(Anti Hunam Interleukin 1 Antibody)와 그의 제법 및 그의 사용법
JPS642572A (en) Polypeptide, dna and use thereof
Herrmann et al. The high affinity interleukin 2 receptor: Fvidence for three distinct polypeptide chains comprising the high affinity interleukin 2 receptor
Eilat et al. Secretion of a soluble, chimeric gamma delta T-cell receptor-immunoglobulin heterodimer.
WO1996023884A3 (en) Human peroxisome proliferator activated receptors
Takata et al. The role of the carboxyl-terminal 6 amino acid extension of human TSH β subunit
EP0200350A3 (de) Nukleinsäure mit Code für ein T-Zellen-Antigenrezeptor-Polypeptid
OHNO et al. Production of a monoclonal antibody that defines the α-subunit of the feline IL-2 receptor
Robb et al. T-cell growth factor: purification, interaction with a cellular receptor, and in vitro synthesis
WO1987004466A1 (en) Interleukin
RIMSKY et al. PRODUCTION, PURIFICATION AND BIOLOGICAL ACTIVITIES OF NATURAL HUMAN INTERLEUKIN 2.
Marx More on the T-Cell receptor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19871107

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SAITO, HARUO

Inventor name: EISEN, HERMAN N.

Inventor name: TONEGAWA, SUSUMU

Inventor name: KRANZ, DAVID M.